Airway hyperresponsiveness in patients treated with omalizumab

Pasquale Capano (Agropoli, Italy), Pasquale Capano, Diomira Magliacane

Source: International Congress 2015 – Immune mechanisms in the human lung
Session: Immune mechanisms in the human lung
Session type: Thematic Poster Session
Number: 4033
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pasquale Capano (Agropoli, Italy), Pasquale Capano, Diomira Magliacane. Airway hyperresponsiveness in patients treated with omalizumab. Eur Respir J 2015; 46: Suppl. 59, 4033

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016

FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

Assessment of mis-beliefs about bronchial asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Long-term FEV1 decline and airway hyperresponsiveness in asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Can forced oscillation technique parameters predict airway hyperresponsiveness to histamine?
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

HDM sublingual AIT tablet is well-tolerated and effective in partly and uncontrolled allergic asthma
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Exercise-induced bronchoconstriction in schoolchildren
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Assessing bronchodilator response (BDR) in preschool children using spirometry
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014


Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013

Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Experience with omalizumab in patients with moderate and severe asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014